Home > Health & Beauty

Health & Beauty

Mesothelioma Cancer Cardio AIDS
Alternative Medicine Biotechnology Clinical Trials
Dental Diabetes FDA
Fitness & Nutrition Genetics Hospitals
Infectious Diseases Medical Devices Medical Supplies
Mental Health Nursing Oncology
Optical Pharmaceutical Radiology
Veterinary
October 31, 2014 16:00
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Visterra, Inc. today announced two key additions to the company’s executive management team and board of directors.
World  World      Biotechnology  Biotechnology
October 31, 2014 16:00
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--NephroGenex, Inc. (NASDAQ:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced that Chief Executive Officer, Pierre Legault will present a corporate overview of the Company and meet with i...
World  World      Biotechnology  Biotechnology
October 31, 2014 16:00
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Insmed Incorporated (Nasdaq: INSM), today announced that the Company will release financial results for the three month and nine months ended September 30, 2014, before the opening of the stock market on Thursday, November 6, 2014. Will Lewis, President and Chi...
World  World      Biotechnology  Biotechnology
October 31, 2014 16:00
HORSHAM, Pa.--(BUSINESS WIRE)--PhotoMedex, Inc. (NasdaqGS and TASE: PHMD) will hold a conference call to discuss the Company’s third quarter 2014 financial results on Thursday, November 6, 2014 at 8:30 a.m. Eastern Time. A press release to announce those results will be issued on November 6th, pr...
World  World      Hospitals  Hospitals
October 31, 2014 15:04
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/clrvpl/global_continuous) has announced the addition of the "Global Continuous Glucose Monitoring Market 2014-2018" report to their offering. The Global Continuous Glucose Monitoring market to grow at a CAGR...
World  World      Diabetes  Diabetes
October 31, 2014 15:00
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia inducible factor (HIF), today announced that John P. Butler, President and Chief Execut...
World  World      Biotechnology  Biotechnology